Search results
-
Progressive Insurance: Making Pay As You Drive a Snap for Consumers - Teaching Note
Farris, Paul W.; Steenburgh, Thomas J.; Maiden, Stephen E.Teaching Note DARDEN-M-0873TN-EMarketingTeaching note for product M-0873Starting at €0.00
-
Red Lobster
Bell, David E.; Riis, JasonCase HBS-511052-EMarketingRed Lobster, a 40-year-old chain of seafood restaurants, has just completed some market research revealing an opportunity to shift their target customer segment. The chain is in the final stages of a 10-year plan of rejuvenation under CEO Kim Lopdrup. When he took over as CEO in 2004 the chain was closing restaurants and suffering declining same store sales and declining customer satisfaction. But in 2010, even in a recession, the fortunes of the...Starting at €8.20
-
PatientsLikeMe: An Online Community of Patients, Teaching Note
Gupta, Sunil; Riis, JasonTeaching Note HBS-511138-EMarketingTeaching Note for 511093.Starting at €0.00
-
H-E-B: Creating a Movement to Reduce Obesity in Texas
Alvarez, Jose B.; Riis, Jason; Salmon, Walter J.Case HBS-512034-EMarketingTo maximize their effectiveness, color cases should be printed in color. In January 2012, H-E-B Grocery Co., a private retail chain with stores located in Texas and Mexico, was introducing its Healthy at H-E-B program to its customers. The program, which started with the company's employees a few years earlier, was an effort to educate and inform customers on how to lead a healthier lifestyle. What CEO Craig Boyan had in mind was creating a state...Starting at €8.20
-
It's the Thoughts that Count (Spanish version)
Ofek, Elie; Riis, Jason; Hamilton, PaulCase HBS-513S30Marketingselecting a target application for the launch of an innovation; determining the importance of having a big name partner for the launch by an unknown start-up; considering the wisdom of taking a B2C rather than B2B approach with a novel technology; using analogous products to forecast demand and sales for a new technology.Starting at €8.20
-
Pricing the EpiPen: This is Going to Sting
Steenburgh, Thomas J.Case DARDEN-M-0915-EMarketingThis case examines the public controversy that erupted over the increasingly high price of EpiPens. Mylan Inc. (Mylan), a generic drug maker, bought the EpiPen product line from Merck in 2007. Since that time, the company both invested in marketing to raise awareness for the drug and dramatically increased the price, lifting it from $100 to $600 per two pack in the U.S. In 2016, simmering consumer anger about the high prices of pharmaceutical dru...Starting at €8.20
-
GlobalGiving
Anik, Lalin; Steenburgh, Thomas J.; Steenburgh, LauraCase DARDEN-M-0938-EMarketingNonprofits are facing a growing challenge to retain donors. At a time when acquiring a new donor is three times as expensive as retaining an existing donor and donor attrition stands at an all-time high, nonprofits are looking to increase the lifetime value of their donors. This case presents a new means by which nonprofits can induce donors to give today and commit to giving in the future. The positive results of a low-cost, high-yield experimen...Starting at €8.20
-
Pricing the EpiPen: This is Going to Sting - Teaching Note
Steenburgh, Thomas J.Teaching Note DARDEN-M-0915TN-EMarketingTeaching note for product M-0915Starting at €0.00
-
Red Lobster (Spanish version)
Bell, David E.; Riis, JasonCase HBS-513S12MarketingRed Lobster, a 40-year-old chain of seafood restaurants, has just completed some market research revealing an opportunity to shift their target customer segment. The chain is in the final stages of a 10-year plan of rejuvenation under CEO Kim Lopdrup. When he took over as CEO in 2004 the chain was closing restaurants and suffering declining same store sales and declining customer satisfaction. But in 2010, even in a recession, the fortunes of the...Starting at €8.20
-
Exercise on Estimation
Riis, Jason; Gourville, John T.Case HBS-509022-EMarketingThis exercise is meant to assess students' level of confidence around everyday business and general knowledge questions, for the purpose of identifying where they are overconfident and underconfident.Starting at €8.20